Gene Expression of Cardiogenic Shock Patients under Extracorporeal Membrane Oxygenation. Gene Expression of Cardiogenic Shock Patients under Extracorporeal Membrane Oxygenation

Prognosis for cardiogenic shock patients under ECMO was our study goal. Success defined as survived more than 7 days after ECMO installation and failure died or had multiple organ failure in 7 days. Total 34 cases were enrolled, 17 success and 17 failure. Peripheral blood mononuclear cells collected at ECMO installation 0hr, 2hr and removal were used analyzed. Overall design: Analysis of the cardiogenic shock patients at extracorporeal membrane oxygenation treatment by genome-wide gene expression. Transcriptomic profiling between successful and failure groups were analyzed.